Clinical Trial Update: Clinical Study on the Treatment of MAFLD With Ganzhixiao Capsules [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Ganzhixiao Capsules for metabolic dysfunction-associated fatty liver disease. The study status is NOT_YET_RECRUITING and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease

Drugs mentioned

• Ganzhixiao Capsules

Snippet

Sponsor: Dong Hui | Conditions: MAFLD | Phase 2 | Status: NOT_YET_RECRUITING